IBM's Clinical Genomics Solution to Help Bring Research From the Bench to the Bedside

IBM and The Cleveland Clinic have unveiled that they have entered into an agreement to develop a translational medicine platform at The Cleveland Clinic. According to the press report the platform will use information from electronic medical records to support basic and genetic research. The goal is to deliver better, more personalised patient care by more easily incorporating research discoveries at the patient bedside.

Under the collaboration, The Cleveland Clinic will be one of the first organisations to use IBM's new clinical genomics solution.